Brief: Adocia announces new BioChaperone program combining a Basal Insulin and GLP-1s
Sept 7 (Reuters) - Adocia SA ADOC.PA
* Adocia announces new BioChaperone program combining a
Basal Insulin and GLP-1s
* Initiation of a clinical study expected in 2017
Source text for Eikon: ID:nBw8vQzFRa
Further company coverage: ADOC.PA
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Adocia SA
See all newsBrief: Adocia And Vester Finance Sign Shareholder Loan Agreement
Brief: Adocia Sees Challenges With GLP-1, Amylin & Other Metabolic Peptides
Brief: Adocia H1 Operating Income EUR -8.932 Million
Brief: Adocia, Tonghua Dongbao Reports Positive Phase 3 Results For Ultra-Rapid Insulin In T2D
Brief: Adocia And Tonghua Dongbao Announce Final Dosing In Phase 3 Clinical Study Of Biochaperone® Lispro